Adherence to TKI in CML patients: more than reports

Support Care Cancer. 2018 Feb;26(2):325-326. doi: 10.1007/s00520-017-3979-y. Epub 2017 Nov 18.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Drug Resistance, Neoplasm
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive*
  • Protein Kinase Inhibitors*

Substances

  • Protein Kinase Inhibitors